Altered T cells have shown promising potential in crossing the blood-brain barrier, allowing for targeted delivery of therapeutic drugs directly to brain tumors, significantly reducing tumor sizes in experimental mice.
Research indicates that these engineered T cells not only combat brain tumors effectively but also help mitigate inflammation in the brain, suggesting a dual therapeutic benefit that enhances overall treatment efficacy.
Collection
[
|
...
]